Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    10364004 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Dose-Effect of S-Tenatoprazole-Na(STU-Na) 30 mg, 60 mg, 90 mg and 120 mg in Healthy Volunteers
Conditions: Esophagitis;   Gastroesophageal Reflux;   Stomach Ulcer;   Duodenal Ulcer
Intervention: Drug: S-Tenatoprazole-Na (STU-Na)
2 Suspended Efficiency Study of S-Tenatoprazole-Na to Treat Erosive or Ulcerative Esophagitis
Condition: Esophagitis, Reflux
Intervention: Drug: S-Tenatoprazole-Na (STU-Na)

Indicates status has not been verified in more than two years